Literature DB >> 9224759

Dedifferentiated acinic cell carcinoma of the parotid gland: a distinct rarely described entity.

J D Henley1, W A Geary, C L Jackson, C D Wu, D R Gnepp.   

Abstract

A case of dedifferentiated acinic cell carcinoma of the parotid gland is presented. A 46-year-old man presented with a parotid gland mass. At surgery the tumor was found adherent to the temporal bone and cervical adenopathy was present. Treatment included radical parotidectomy and intraoperative radiotherapy. Histologically, the tumor was a composite of a usual low-grade acinic cell carcinoma and high-grade, poorly differentiated carcinoma. Cervical lymph node metastases were composed entirely of high-grade carcinoma. Immunohistochemically, both low- and high-grade malignant components were negative for p53 oncoprotein expression. Moreover, polymerase chain reaction and nonisotopic single-stranded conformational polymorphism analyses were consistent with a germ line configuration of the p53 gene, exons five through eight, in both low- and high-grade elements of the tumor. The literature on this unusual variant of acinic cell carcinoma is reviewed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9224759     DOI: 10.1016/s0046-8177(97)90164-7

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  15 in total

1.  Primary epithelial-myoepithelial carcinoma of the lung: A case report demonstrating high-grade transformation-like changes.

Authors:  Shogo Tajima; Michihiko Aki; Kiyoshige Yajima; Tsuyoshi Takahashi; Hiroshi Neyatani; Kenji Koda
Journal:  Oncol Lett       Date:  2015-04-30       Impact factor: 2.967

Review 2.  Anaplastic myoepithelial carcinoma of the sinonasal tract: an underrecognized salivary-type tumor among the sinonasal small round blue cell malignancies? Report of one case and a review of the literature.

Authors:  Fredrik Petersson; Siew Shuen Chao; Siok Bian Ng
Journal:  Head Neck Pathol       Date:  2010-11-21

3.  Dedifferentiated acinic cell tumour: the harlequin of salivary gland neoplasms--an unusual variant.

Authors:  Anshu Jain; Kiran Alam; Aroonima Misra; Veena Maheshwari
Journal:  BMJ Case Rep       Date:  2013-05-27

4.  Salivary gland hybrid tumour revisited: could they represent high-grade transformation in a low-grade neoplasm?

Authors:  Henrik Hellquist; Alena Skalova; Bahram Azadeh
Journal:  Virchows Arch       Date:  2016-09-07       Impact factor: 4.064

5.  Malignant transformation of sialadenoma papilliferum of the palate: a case report.

Authors:  Masayuki Shimoda; Kaori Kameyama; Shojiroh Morinaga; Youichi Tanaka; Kazuhiro Hashiguchi; Megumi Shimada; Yasunori Okada
Journal:  Virchows Arch       Date:  2004-09-29       Impact factor: 4.064

6.  Clinicopathologic and Immunophenotypic Characterization of 25 Cases of Acinic Cell Carcinoma with High-Grade Transformation.

Authors:  Lester D Thompson; Muhammad N Aslam; Jennifer N Stall; Aaron M Udager; Simion Chiosea; Jonathan B McHugh
Journal:  Head Neck Pathol       Date:  2015-08-06

7.  The monoclonal anti-BCL10 antibody (clone 331.1) is a sensitive and specific marker of pancreatic acinar cell carcinoma and pancreatic metaplasia.

Authors:  Stefano La Rosa; Francesca Franzi; Silvia Marchet; Giovanna Finzi; Moira Clerici; Davide Vigetti; Anna Maria Chiaravalli; Fausto Sessa; Carlo Capella
Journal:  Virchows Arch       Date:  2008-12-09       Impact factor: 4.064

8.  High Grade Transformation in Mucoepidermoid Carcinoma of the Minor Salivary Gland with Polyploidy of the Rearranged MAML2 Gene.

Authors:  Hyun Lee; Jong-Lyel Roh; Young-Jun Choi; Jene Choi; Kyung-Ja Cho
Journal:  Head Neck Pathol       Date:  2019-09-18

Review 9.  "Dedifferentiation" and high-grade transformation in salivary gland carcinomas.

Authors:  Toshitaka Nagao
Journal:  Head Neck Pathol       Date:  2013-07-03

10.  NR4A3 Immunohistochemistry Reliably Discriminates Acinic Cell Carcinoma from Mimics.

Authors:  Kristine S Wong; Adrian Mariño-Enriquez; Jason L Hornick; Vickie Y Jo
Journal:  Head Neck Pathol       Date:  2020-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.